China Biotech IPO Drought Lingers But HK Sees First Of 2024

 
• By Dexter Jie Yan

Biotech IPOs on the Chinese mainland have dried up since June 2023 due to regulatory tightening, but Hong Kong is still open to listings of pre-revenue ventures and has seen its first offering of this year.

IPO
Dearth of China mainland IPOs since last June but Hong Kong sees 2024's first • Source: Shutterstock

More from Financing

More from Business